Get the latest research and practical clinical applications from the SNMMI 2025 Annual Meeting, including focused coverage on genitourinary cancer data.
Conference Coverage
Coverage of the major medical conferences that impact genitourinary oncology professionals.
2025
2024
2023
2022
GU Oncology Now delivers the latest genitourinary oncology conference coverage, highlighting advancements in treatments and tech.
Get exclusive conference news straight to your inbox.
Knowledge Hub Spotlights
Curated clinical content based on conditions, therapies, and technologies
Roundtables
Clinical discussions with experts in the field
The panel concludes with a discussion on the future of prostate cancer treatment, emphasizing the pursuit of cures.
The panel transitions to the evolving use of Lutetium-177, including from a post-chemo to a pre-chemo indication.
The panel considers the use of radium-223, PARP inhibitors, and other therapies for patients with mCRPC.
The panel highlights the management of oligomets and the process for targeting small-volume mets to delay progression.
The panel discusses imaging and early indicators of disease progression in metastatic castration-sensitive prostate cancer.
The panel explores the role of germline and somatic genetic testing in managing metastatic CSPC.